Gary Lubin

CEO at Ledger Run, Inc. - powering ClinRun

Gary Lubin is a seasoned executive with extensive experience in various roles across the healthcare and pharmaceutical industry. Gary is currently the CEO of Ledger Run, Inc., a company they co-founded in 2018. Under their leadership, Ledger Run focuses on simplifying and expediting clinical trials by utilizing innovative technological solutions. Gary has assembled a team of domain experts that understand the challenges involved in activating research sites, and the company offers a suite of integrated solutions that deliver immediate impact to sponsors, CROs, and research sites.

Prior to their current role, Gary served as the Co-Lead at InRun Capital from 2015 onwards. Gary was also instrumental in the turnaround and successful exit of PDR Network, LLC, where they held the position of CFO and EVP from 2013 to 2015. PDR Network is a leading distributor of FDA-approved drug labeling and safety information.

In 2008, Gary founded Centerphase Solutions, a technology-based clinical services company aimed at improving clinical trial performance. Gary served as the President and CEO until 2013. Centerphase was formed through a collaboration with Mayo Clinic.

Before Centerphase, Gary held multiple roles at Merck Capital Ventures from 1992 to 2008. Gary co-founded the venture capital fund and served as the Managing Director and CIO/CTO. In this capacity, they were responsible for all aspects of running the fund, including investment strategy, deal structuring, and managing the investment portfolio. Additionally, Gary held various high-level positions within Merck-Medco, where they played a significant role in improving customer retention, generating cost savings, and leading business operations.

Overall, Gary Lubin's work experience showcases their expertise in leadership, innovation, and strategic decision-making within the healthcare and pharmaceutical industry.

Gary Lubin has a strong educational background in business and accounting. Gary obtained a Bachelor of Science in Business Administration (BSBA) with a specialization in Accounting from Washington University in St. Louis - Olin Business School. This occurred between 1979 and 1982. Later, from 1984 to 1986, they pursued a Master of Business Administration (MBA) degree with a focus on Business from Harvard Business School. Additionally, they hold some additional certifications, namely CGMA, CITP, and CPA, although there is no information provided about the institutions or years of obtaining these certifications.

Links

Previous companies

Merck logo

Timeline

  • CEO

    October, 2018 - present